Transgenomic (TBIO) Licenses Long QT Syndrome DNA Testing Portfolio to LabCorp (LH)
Tweet Send to a Friend
Transgenomic, Inc. (TBIO), (NASDAQ: TBIO), today announced that it has signed a commercial license agreement with Laboratory Corporation of America® ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE